Daniel Salain
Chief Operating Officer at ACERAGEN, INC.
Net worth: 1 M $ as of 2023-07-30
Profile
Daniel Salain is currently the Chief Operating Officer at Aceragen, Inc. (North Carolina) and Aceragen, Inc. He previously held positions as the Chief Operating Officer at Idera Pharmaceuticals, Inc., Vice President-Global Supply Chain & Manufacturing at Aptalis Pharma, Inc., Chief Operations & Technology Officer at Graybug Vision, Inc., Senior Vice President-Technical Operations at IVERIC bio, Inc., and Vice President-Operations at Eurand Pharmaceuticals, Inc. Mr. Salain completed his undergraduate degree at the University of Indianapolis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ACERAGEN, INC.
17.45% | 2023-07-18 | 1,469,482 ( 17.45% ) | 1 M $ | 2023-07-30 |
Daniel Salain active positions
| Companies | Position | Start |
|---|---|---|
| ACERAGEN, INC. | Chief Operating Officer | 2020-05-31 |
Aceragen, Inc. (North Carolina)
 Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Chief Operating Officer | 2020-05-31 |
Former positions of Daniel Salain
| Companies | Position | End |
|---|---|---|
| CALCIMEDICA, INC. | Chief Operating Officer | 2020-04-30 |
| IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | 2017-10-31 |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 2014-10-31 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Chief Operating Officer | - |
| Eurand Pharmaceuticals, Inc. | Chief Operating Officer | - |
Training of Daniel Salain
| University of Indianapolis | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACERAGEN, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
| Eurand Pharmaceuticals, Inc. | Health Technology |
Aceragen, Inc. (North Carolina)
Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Daniel Salain
